Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

SUIT-015

From Bioblast


high-resolution terminology - matching measurements at high-resolution


SUIT-015

Description

1OctM;2D;3G;4P;5S;6U;7Rot-.png

Abbreviation: FNS(Oct,PGM)

Reference: A Schoepf 2016 FEBS J


MitoPedia concepts: SUIT protocol, SUIT B 

SUIT-category: FNS(Oct,PGM)
SUIT protocol pattern: diametral 1OctM;2D;3G;4P;5S;6U;7Rot


References

 YearReferenceOrganismTissue;cell
Schoepf 2016 FEBS J2016Schöpf B, Schäfer G, Weber A, Talasz H, Eder IE, Klocker H, Gnaiger E (2016) Oxidative phosphorylation and mitochondrial function differ between human prostate tissue and cultured cells. https://doi.org/10.1111/febs.13733HumanEndothelial;epithelial;mesothelial cell
Genital
Other cell lines
Fibroblast

Template:SUIT-0XX

Strengths and limitations

+ The protocol provides information on FAO capacity in the absence of other, potentially interfering pathways, both in the LEAK state and in OXPHOS.
+ FNS OXPHOS capacity comprises the most important pathways in many cell types and thus provides a physiologically relevant estimate of maximum mitochondrial respiratory capacity.
+ FNS ET capacity is a good estimate of overal ET capacity in may cell types.
+ Application of the cytochrome c test early in the protocol ensures comparability of all states in case of any effect of c.
+ Reasonable duration of the experiment.
- SRot(E) may be underestimated if S is not saturating.
- CIV activity is not measured, to save experimental time.


- GM and PM yield typically identical fluxes in human skeletal muscle fibres. However, PM is the superior alternative to GM: the fraction of the N-pathway is lower and of the S-pathway is higher with GM compared to PM (GMP is inhibited by the CII inhibitor malonic acid to a larger extent than PMP). PM, therefore, yields a more sensitive assay for the diagnosis of injuries in the N-pathway, since an impairment of N-pathway capacity can be compensated partially by activation of the S-pathway. This is a disadvantage compared to SUIT-004 and SUIT-008 for diagnosis of N-capacity.
- To detect an additive effect of P after GMP, pyruvate would have to be added as step 3 (before S). However, inhibition of respiration was observed after titration of P (5 mM) in horse skeletal muscle fibres (Votion et al 2012), which was not the case when P was titrated in steps of 1 mM.
- When evaluating the additive effect of the N- and S-pathway, it has to be considered that NSP- and NSE-capacities can only be compared with NP- and SE-capacities. This is not a problem when NSP = NSE (Gnaiger 2009). Otherwise, it may be assumed that SP = SE (Votion et al 2012), such that NSP can be compared with NP + SP. SUIT-004 should be chosen for the additive effect in the ET-state.
- Rox may be lower in substrate states earlier in the SUIT protocol. Therefore, this Rox measurement is frequently taken as a methodological control rather than as the final basis of Rox correction of mitochondrial respiration (mt).
- Careful washing is required after the experiment to avoid carry-over of inhibitors and uncoupler.


Compare SUIT protocols


1GM;2D;3S;3c;4U;5Rot-.jpg 1GM;2D;3S;3c;4U;5Rot;6Ama


MitoPedia concepts: SUIT protocol, SUIT A